Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-02 | Editas Medicine, Inc. | Lucera Erick
(EVP, CHIEF FINANCIAL OFFICER) |
A | Common Stock | A | 61266 | $0.00 - $0.00 | $0 |
2024-03-02 | Editas Medicine, Inc. | Burkly Linda
(EVP, CHIEF SCIENTIFIC OFFICER) |
A | Common Stock | A | 39855 | $0.00 - $0.00 | $0 |
2024-03-04 | Editas Medicine, Inc. | Mei Baisong
(SVP, CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 20327 | $9.42 - $9.42 | $191,425 |
2024-03-02 | Editas Medicine, Inc. | Mei Baisong
(SVP, CHIEF MEDICAL OFFICER) |
A | Common Stock | A | 89815 | $0.00 - $0.00 | $0 |
2023-12-05 | Editas Medicine, Inc. | Eaton Bruce
(EVP, CBO AND CTO) |
S | Common Stock | D | 103 | $10.90 - $10.90 | $1,122 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |